NCT03789240 2026-03-03
Response-Adapted Therapy With Copanlisib and Rituximab in Untreated Follicular Lymphoma
National Institutes of Health Clinical Center (CC)
Phase 2 Active not recruiting
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's